methylthio-adp has been researched along with nf023 in 1 studies
| Studies (methylthio-adp) | Trials (methylthio-adp) | Recent Studies (post-2010) (methylthio-adp) | Studies (nf023) | Trials (nf023) | Recent Studies (post-2010) (nf023) |
|---|---|---|---|---|---|
| 146 | 2 | 43 | 6 | 0 | 2 |
| Protein | Taxonomy | methylthio-adp (IC50) | nf023 (IC50) |
|---|---|---|---|
| P2X purinoceptor 1 | Homo sapiens (human) | 0.21 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jacobson, KA; Jarvis, MF; Williams, M | 1 |
1 review(s) available for methylthio-adp and nf023
| Article | Year |
|---|---|
Purine and pyrimidine (P2) receptors as drug targets.
Topics: Adenosine Triphosphate; Animals; Drug Design; Humans; Ligands; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Pyrimidines; Receptors, Purinergic P2; Uridine Triphosphate | 2002 |